Tenet Healthcare Corporation
$189.93
▲
2.4%
2026-04-22 10:12:13
www.tenethealth.com
NYQ: THC
Explore Tenet Healthcare Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$16.56 B
Current Price
$189.93
52W High / Low
$247.21 / $109.82
Stock P/E
12.26
Book Value
$48.53
Dividend Yield
—
ROCE
13.64%
ROE
27.02%
Face Value
—
EPS
$15.49
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
77,000
Beta
1.5
Debt / Equity
160.79
Current Ratio
1.76
Quick Ratio
1.68
Forward P/E
11.12
Price / Sales
0.81
Enterprise Value
$33.28 B
EV / EBITDA
7.18
EV / Revenue
1.56
Rating
Strong Buy
Target Price
$261.38
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Valuation is not stretched on P/E basis.
Cons
- Leverage is relatively high.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | DaVita Inc. | $149.93 | 15.78 | $10.02 B | — | 14.02% | 64.85% | $159.42 / $101 | $-9.5 |
| 2. | biote Corp. | $2.24 | 3.25 | $87.8 M | — | 56.77% | -32.89% | $4.75 / $1.27 | $-1.91 |
| 3. | Addus HomeCare Corporation | $93.52 | 18.23 | $1.75 B | — | 10.76% | 9.33% | $124.44 / $90.89 | $59.84 |
| 4. | The Pennant Group, Inc. | $29.64 | 35.03 | $1.04 B | — | 6.2% | 9.84% | $35 / $21.73 | $9.54 |
| 5. | Pediatrix Medical Group, Inc. | $23.19 | 11.69 | $1.93 B | — | 12.93% | 20.28% | $24.99 / $11.84 | $10.68 |
| 6. | P3 Health Partners Inc. | $2.83 | — | $18.75 M | — | -242.67% | -69.53% | $11.3 / $1.52 | $-47.24 |
| 7. | Nutex Health Inc. | $109.28 | 11.86 | $761.5 M | 9.75% | 36.24% | 58.94% | $193.07 / $77.21 | $46.49 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 5.53 B | 5.29 B | 5.27 B | 5.22 B | 5.07 B | — |
| Operating Profit | 869 M | 817 M | 852 M | 901 M | 777 M | — |
| Net Profit | 371 M | 342 M | 288 M | 406 M | 318 M | — |
| EPS in Rs | 4.27 | 3.93 | 3.31 | 4.67 | 3.66 | 4.89 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 21.31 B | 20.68 B | 20.56 B | 19.17 B |
| Operating Profit | 3.44 B | 2.92 B | 2.44 B | 2.41 B |
| Net Profit | 1.41 B | 3.2 B | 611 M | 411 M |
| EPS in Rs | 16.18 | 36.8 | 7.03 | 4.73 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 29.68 B | 28.94 B | 28.31 B | 27.16 B |
| Total Liabilities | 20.7 B | 20.39 B | 22.8 B | 22.55 B |
| Equity | 4.22 B | 4.17 B | 1.61 B | 1.14 B |
| Current Assets | 7.85 B | 7.68 B | 7.17 B | 5.98 B |
| Current Liabilities | 4.46 B | 4.31 B | 4.76 B | 4.48 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 3.54 B | 2.05 B | 2.37 B | 1.08 B |
| Investing CF | -1.27 B | 3.43 B | -969 M | -808 M |
| Financing CF | -2.4 B | -3.69 B | -1.03 B | -1.78 B |
| Free CF | 2.53 B | 1.12 B | 1.62 B | 321 M |
| Capex | -1.01 B | -931 M | -751 M | -762 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.54% | 7.25% | — | — |
| Earnings Growth % | 423.73% | 48.66% | — | — |
| Profit Margin % | 15.48% | 2.97% | 2.14% | — |
| Operating Margin % | 14.11% | 11.88% | 12.58% | — |
| Gross Margin % | 82.36% | 82.54% | 82.93% | — |
| EBITDA Margin % | 33.33% | 16.48% | 16.04% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.